LAB-OMICS AND PROGNOSTIC MARKERS

Randy L. Jensen(University of Utah), Ken Aldape(The University of Texas MD Anderson Cancer Center), Emanuele Palescandolo(Harvard University), Alexandra Borges, Sandro Santagata(Harvard University), Keith L. Ligon(Brigham and Women's Hospital), Priscilla K. Brastianos(Massachusetts General Hospital), Jaap C. Reijneveld(Amsterdam UMC Location University of Amsterdam), Mark L. Cohen(University Hospitals Cleveland Medical Center), Robert T. Jones(MedStar Franklin Square Medical Center), Gregor Hütter(University Hospital of Basel), Brian Patrick O’Neill(Henry Ford Health System), J. J. Heimans(Neurology, Inc), Shaji Abraham, Hinke F. van Thuijl, Gaddy Getz(Broad Institute), Erik Vassella(University of Bern), Peleg Horowitz(Brigham and Women's Hospital), Rameen Beroukhim(Broad Institute), Ilari Scheinin, Aaron McKenna(Dartmouth College), Pieter Wesseling(Radboud University Nijmegen), István Vajtai, SJ Felten, Dirk F. van Essen, Juergen Hench, Matthias Schulz, William C. Hahn(Broad Institute), Jaime Vengoechea(University Hospitals Cleveland Medical Center), Jean‐Louis Boulay, Sebastián Cerdán, Daniel J. Brat(Northwestern University), Angela Sloan, Severina Leu, Sander B. Frank(Van Andel Institute), Martin Sailer, Y. Chen, Luigi Mariani(Fondazione IRCCS Istituto Nazionale dei Tumori), Anat Stemmer‐Rachamimov(Massachusetts General Hospital), Sheng Zheng, Nan Hu(Singapore Management University), Ian F. Dunn(University of Oklahoma), J. M. Bravo Marques, X. Guan, David N. Louis(Harvard University), Bauke Ylstra(Amsterdam University Medical Centers), Elisabeth Taylor, Paul Van Hummelen
Neuro-Oncology
October 1, 2012
Cited by 1


Related Papers